- Article
Characterising a Novel Therapeutic Target for Psoriasis, TYK2, Using Functional Genomics
- Shraddha S. Rane,
- Sarah Elyoussfi,
- Elan Shellard,
- Steve Eyre and
- Richard B. Warren
Psoriasis (Ps) is a debilitating immune-mediated chronic skin condition. It affects about 1–3% of the world population, with an 8–11% prevalence in Northern European populations. Tyrosine kinase 2 (TYK2) is a newly identified target for P...

